For patients with chronic migraine — 15 or more headache days per month, with migraine features on at least 8 of those days — botulinum toxin is a clinically validated preventive (prophylactic) treatment listed in international neurology guidelines. For patients who have become dependent on analgesics or who do not respond to standard preventives, this therapy can open a new chapter.
How Does Migraine Botox Work?
Botulinum toxin's mechanism in migraine differs from its aesthetic use. The primary targets here are not muscles but the peripheral nerve endings that transmit pain signals. Toxin injected into specific zones suppresses the release of nociceptive neuropeptides such as CGRP (calcitonin gene-related peptide) and substance P. These mediators play a critical role in pain transmission and in the formation of neurogenic inflammation in the meninges. Suppressing their release makes attacks harder to start and, when they do start, makes them shorter and less severe.
The standard FDA-approved PREEMPT protocol places 155 units of Botox across 31 fixed points spanning the forehead, temples, occiput, neck and shoulder muscles — each point selected from a precisely defined anatomical map.
Who Benefits?
Adults diagnosed with chronic migraine — at least 3 months with 15+ headache days per month, of which at least 8 have migraine features — are the primary target group. The therapy is particularly valuable for patients who have tried topiramate, valproate, beta-blockers or tricyclic antidepressants without adequate response or who could not tolerate side effects.
Patients who have developed medication-overuse (rebound) headache also benefit, as migraine Botox offers an opportunity to reduce analgesic consumption. A neurology evaluation — and, where indicated, imaging — is recommended before starting treatment.
Treatment Course and Expectations
Migraine Botox is not a one-time procedure; it is a prophylactic programme repeated every 12 weeks. Attack frequency typically begins to decrease 2–3 weeks after the first session. Full and durable response usually requires 2 or 3 sessions (6–9 months). Clinical studies show that around 70% of patients who complete this protocol experience a clinically meaningful reduction in attack frequency.
Each session takes 20–30 minutes. Patients feel mild pressure during the injections; the very fine needle gauge keeps the procedure well tolerated. Daily activities can resume immediately afterwards.
Follow-up and Long-term Plan
Throughout the treatment course, attack frequency, severity, duration and analgesic consumption are tracked — a migraine diary makes the progress concrete and helps optimise the protocol. In responders, therapy can be continued for two years or more. The long-term safety profile is well documented and the treatment does not lead to dependence.
Let's evaluate whether migraine Botox is right for you.
Book Now